Target intelligence / Profile preview

Ubiquitin specific peptidase 32 pseudogene 2 (USP32P2)

Target: USP32P2
Molecular classification: Other (Pseudogene)

Overview

USP32P2 is annotated as a pseudogene—a nonfunctional genomic locus related to ubiquitin specific peptidase 32 (USP32)—and does not encode an active protein. Its biological significance, if any, is unclear; available data relate to its parent gene USP32, a deubiquitinating enzyme implicated in cellular protein regulation, cancer biology, and drug resistance, but USP32P2 itself is not a drug target and has no established therapeutic relevance[1].

Other names: TL132USP32P2

Beyond the preview

Go deeper on Ubiquitin specific peptidase 32 pseudogene 2 (USP32P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 32 pseudogene 2 (USP32P2).

Explore the full profile